Christopher P. Dall, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystectomy | 5 | 2024 | 603 | 1.650 |
Why?
|
Urinary Incontinence | 3 | 2024 | 490 | 0.960 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2024 | 2176 | 0.950 |
Why?
|
Prostatectomy | 4 | 2024 | 1786 | 0.810 |
Why?
|
Vas Deferens | 1 | 2020 | 55 | 0.720 |
Why?
|
Vena Cava, Inferior | 1 | 2022 | 463 | 0.650 |
Why?
|
Hospitals, Teaching | 1 | 2024 | 1156 | 0.650 |
Why?
|
Hernia, Inguinal | 1 | 2020 | 224 | 0.580 |
Why?
|
Enoxaparin | 1 | 2020 | 391 | 0.580 |
Why?
|
Prostate | 2 | 2024 | 1758 | 0.530 |
Why?
|
Fallopian Tubes | 1 | 2017 | 179 | 0.530 |
Why?
|
Urology | 1 | 2020 | 384 | 0.490 |
Why?
|
Prostatic Neoplasms | 7 | 2025 | 11094 | 0.460 |
Why?
|
Postoperative Complications | 5 | 2024 | 15808 | 0.450 |
Why?
|
Hospitals | 1 | 2024 | 3887 | 0.370 |
Why?
|
Nephrectomy | 2 | 2024 | 928 | 0.320 |
Why?
|
Kidney Neoplasms | 3 | 2024 | 4282 | 0.320 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3407 | 0.310 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1883 | 0.280 |
Why?
|
Androgen Receptor Antagonists | 2 | 2024 | 123 | 0.280 |
Why?
|
Cell Survival | 1 | 2016 | 5747 | 0.260 |
Why?
|
Lymph Nodes | 1 | 2017 | 3456 | 0.250 |
Why?
|
Anticoagulants | 1 | 2020 | 4857 | 0.230 |
Why?
|
Oxygen | 1 | 2016 | 4247 | 0.230 |
Why?
|
Urogenital Neoplasms | 1 | 2024 | 130 | 0.210 |
Why?
|
Fascia | 1 | 2024 | 143 | 0.210 |
Why?
|
Stem Cells | 1 | 2016 | 3537 | 0.210 |
Why?
|
Myocardium | 1 | 2016 | 4766 | 0.210 |
Why?
|
Retroperitoneal Space | 1 | 2022 | 175 | 0.200 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3186 | 0.190 |
Why?
|
Urologic Surgical Procedures | 1 | 2024 | 281 | 0.190 |
Why?
|
Inflammation | 1 | 2020 | 10860 | 0.180 |
Why?
|
Hydronephrosis | 1 | 2022 | 274 | 0.180 |
Why?
|
Erectile Dysfunction | 1 | 2024 | 437 | 0.180 |
Why?
|
Urologic Neoplasms | 1 | 2024 | 312 | 0.170 |
Why?
|
Hospital Mortality | 2 | 2024 | 5340 | 0.170 |
Why?
|
Ureteral Obstruction | 1 | 2022 | 293 | 0.170 |
Why?
|
Ureter | 1 | 2022 | 364 | 0.160 |
Why?
|
Medicare | 4 | 2025 | 6820 | 0.160 |
Why?
|
Chemoprevention | 1 | 2020 | 327 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20700 | 0.140 |
Why?
|
GATA3 Transcription Factor | 1 | 2017 | 163 | 0.130 |
Why?
|
Adrenocortical Carcinoma | 1 | 2017 | 88 | 0.130 |
Why?
|
Pheochromocytoma | 1 | 2017 | 326 | 0.120 |
Why?
|
Treatment Outcome | 4 | 2024 | 65219 | 0.110 |
Why?
|
Aftercare | 1 | 2020 | 915 | 0.110 |
Why?
|
Anemia | 1 | 2022 | 1514 | 0.100 |
Why?
|
Humans | 17 | 2025 | 766117 | 0.100 |
Why?
|
Melanins | 1 | 2014 | 290 | 0.100 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2017 | 731 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2025 | 59515 | 0.090 |
Why?
|
Male | 9 | 2025 | 363935 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1262 | 0.090 |
Why?
|
United States | 5 | 2025 | 72920 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6490 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3283 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7237 | 0.080 |
Why?
|
Quality of Health Care | 1 | 2024 | 4306 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2890 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12976 | 0.070 |
Why?
|
Light | 1 | 2014 | 1358 | 0.070 |
Why?
|
Aged | 5 | 2025 | 171219 | 0.060 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1411 | 0.060 |
Why?
|
Iron | 1 | 2014 | 1811 | 0.060 |
Why?
|
Androstenes | 1 | 2024 | 177 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2025 | 2824 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13468 | 0.050 |
Why?
|
Female | 4 | 2024 | 396233 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2025 | 81565 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 578 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2024 | 1088 | 0.040 |
Why?
|
Androgens | 1 | 2024 | 1278 | 0.030 |
Why?
|
Drug Costs | 1 | 2025 | 1195 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4016 | 0.030 |
Why?
|
Hospital Costs | 1 | 2022 | 955 | 0.030 |
Why?
|
Sepia | 1 | 2014 | 1 | 0.030 |
Why?
|
Adult | 2 | 2020 | 223139 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2025 | 13635 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3191 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2014 | 749 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2221 | 0.020 |
Why?
|
Animals | 2 | 2016 | 168800 | 0.020 |
Why?
|
Prognosis | 1 | 2022 | 29912 | 0.010 |
Why?
|